TP53 and breast cancer: There is weak evidence linking the germline PVs in TP53, CDH1, and PTEN with a higher risk of BC in men, and the testing of such genes should be guided by the clinical characteristics of the associated syndromes (Li Fraumeni, Hereditary Diffuse Gastric Cancer, and Cowden, respectively) [92].